These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 5381603

  • 1. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM, Efimov VS, Polonskaia LB.
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract] [Full Text] [Related]

  • 2. On the action mechanism of some fibrinolysis inhibitors.
    Donner L, Housková J.
    Thromb Diath Haemorrh; 1967 Dec 31; 18(3-4):439-46. PubMed ID: 4952977
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of fibrinolysis inhibitors on tissue changes produced by hexadimethrinbromide].
    Szijj I, Kovács K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Dec 31; 91(4):487-95. PubMed ID: 4184475
    [No Abstract] [Full Text] [Related]

  • 4. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M, Pavlu C.
    Arzneimittelforschung; 1966 May 31; 16(5):671-3. PubMed ID: 6014440
    [No Abstract] [Full Text] [Related]

  • 5. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP, Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 May 31; 92(1):84-9. PubMed ID: 4189378
    [No Abstract] [Full Text] [Related]

  • 6. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F.
    Internist (Berl); 1966 Aug 31; 7(8):400-5. PubMed ID: 4863412
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The development of fibrinolysis inhibitors].
    Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967 Aug 31; 87(1):5-14. PubMed ID: 4173881
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G, Frick U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966 Aug 31; 86(4):389-403. PubMed ID: 4168276
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W, Priester LI, Stiller DW, Duncan AE, Ciminera JL, Loeffler LJ.
    Thromb Diath Haemorrh; 1969 Nov 15; 22(2):263-72. PubMed ID: 5380948
    [No Abstract] [Full Text] [Related]

  • 18. [Inhibitors of fibrinolysis. (Review)].
    Merkulov MF, Maliugina IB.
    Farmakol Toksikol; 1969 Nov 15; 32(3):362-75. PubMed ID: 4897617
    [No Abstract] [Full Text] [Related]

  • 19. [On the mechanism of the effect of various inhibitors of fibrinolysis].
    Donner L, Housková J.
    Sb Lek; 1967 Nov 15; 69(11):343-51. PubMed ID: 5299789
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.